Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab

BACKGROUND: Triple negative breast cancer (TNBC) remains the most challenging breast cancer subtype so far. Specific therapeutic approaches have rarely achieved clinical improvements in treatment of TNBC patients and effective molecular biomarkers are largely unknown. METHODS: We used paired TNBC sa...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Mol Cancer
Hoofdauteurs: Li, Jie, Ma, Maoguang, Yang, Xuesong, Zhang, Maolei, Luo, Jingyan, Zhou, Huangkai, Huang, Nunu, Xiao, Feizhe, Lai, Bingquan, Lv, Weiming, Zhang, Nu
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2020
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7488427/
https://ncbi.nlm.nih.gov/pubmed/32917240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-020-01259-6
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items